Document Detail

Usefulness of resource utilization estimates from piggyback studies in rheumatoid arthritis.
MedLine Citation:
PMID:  19807346     Owner:  NLM     Status:  In-Data-Review    
Several methods to derive estimates of resource utilization for pharmacoeconomic evaluations exist. A common method is to collect this information alongside a clinical trial. A common criticism of this data collection strategy is that it may yield inaccurate results as the clinical trial protocol places many restrictions on the study design, patient enrolment and frequency of data collection, which may lead to an artificial picture of resource consumption and costs. In this special report, this problem is examined in rheumatoid arthritis patients. Data were collected from two sources: a Phase III clinical trial with piggyback resource utilization and a cross-sectional database utilizing retrospective recall of resource use. The patients from each database were matched in terms of age, gender and Health Assessment Questionnaire Disability Index and major measures of resource use were compared. The results of this study suggest that there were limitations in the use of patient-reported data to estimate resource utilization in this clinical trial.
Christopher Evans; Bruce Crawford; Joseph Doyle
Related Documents :
18039886 - Computing heritability and selection response from unbalanced plant breeding trials.
14689186 - Advantage of single-trial models for response to selection in wheat breeding multi-envi...
19933716 - Futility interim monitoring with control of type i and ii error probabilities using the...
3275456 - Statistical reasoning in clinical trials: hypothesis testing.
12463816 - End-to-end performance measurement of internet based medical applications.
23522676 - Association between somatic cell count early in the first lactation and the longevity o...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of pharmacoeconomics & outcomes research     Volume:  3     ISSN:  1744-8379     ISO Abbreviation:  Expert Rev Pharmacoecon Outcomes Res     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2009-10-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101132257     Medline TA:  Expert Rev Pharmacoecon Outcomes Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  685-9     Citation Subset:  -    
Mapi Values, 15 Court Square, Suite 620, Boston, MA 02108, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Self-management programs in chronic obstructive pulmonary disease: are they worthy?
Next Document:  Impact of socioeconomic status on cardiovascular outcomes in Canada.